Greg Haljan News Today

The familys car rolled down a ravine, leaving a teenage son with bad head injuries. They are now recovering and grateful to their rescuers.

A day in the life of Surrey Memorials critical care unit, which has treated nearly half of B.C.s COVID ICU patients.

  VANCOUVER -- Declining COVID-19 case numbers have given many British Columbians hope for the summer. The province has promised if specific targets are met, residents could soon enjoy much more freedom. But for the professionals working tirelessly inside Surrey Memorial Hospital’s COVID-19 intensive care unit, the fight is far from over. "I think itll be pretty overwhelming when you sit and reflect on everything thats gone on because weve seen a lot, its been very traumatic," says Manjo...

  TORONTO -- At a clinic in Surrey, B.C., some newly diagnosed COVID-19 patients are receiving a therapy that few other Canadians can get. The Canadian-made treatment is called bamlanivimab, and it involves infusing patients with monoclonal antibodies within three days of testing positive, all with the aim of preventing their illness from progressing into life-threatening. Bamlanivimab has been approved and used around the world in more than 400,000 patients, but the treatment is contentio...

  VANCOUVER -- The head of a Vancouver-based biotech company says he’s frustrated at the delay in delivering what he calls a potentially "life-saving" COVID-19 treatment. Carl Hansen is the CEO of AbCellera, which discovered an antibody treatment for the virus last year. In partnership with Eli Lilly Canada, the two companies developed the drug bamlanivimab. It was first approved for emergency use by Health Canada in November, shortly after FDA approval in the U.S. Since then, Hansen say...